Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CARPENTER WT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 79 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Thaker, GK; Carpenter, WT
      Advances in schizophrenia

      NATURE MEDICINE
    2. Avila, MT; Conley, RR; Carpenter, WT
      A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research

      BIOLOGICAL PSYCHIATRY
    3. Kirkpatrick, B; Buchanan, RW; Ross, DE; Carpenter, WT
      A separate disease within the syndrome of schizophrenia

      ARCHIVES OF GENERAL PSYCHIATRY
    4. Carpenter, WT
      Evidence-based treatment for first-episode schizophrenia?

      AMERICAN JOURNAL OF PSYCHIATRY
    5. Lahti, AC; Holcomb, HH; Medoff, DR; Weiler, MA; Tamminga, CA; Carpenter, WT
      Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task

      AMERICAN JOURNAL OF PSYCHIATRY
    6. Breier, A; Buchanan, RW; Irish, D; Carpenter, WT
      Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns

      PSYCHIATRIC SERVICES
    7. Carpenter, WT; Breier, A; Buchanan, RW; Kirkpatrick, B; Shepard, P; Weiner, E
      Mazindol treatment of negative symptoms

      NEUROPSYCHOPHARMACOLOGY
    8. Carpenter, WT; Conley, R; Kirkpatrick, B
      On schizophrenia and new generation drugs

      NEUROPSYCHOPHARMACOLOGY
    9. Kirkpatrick, B; Kopelowicz, A; Buchanan, RW; Carpenter, WT
      Assessing the efficacy of treatments for the deficit syndrome of schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    10. Kirkpatrick, B; Castle, D; Murray, RM; Carpenter, WT
      Risk factors for the deficit syndrome of schizophrenia

      SCHIZOPHRENIA BULLETIN
    11. Carpenter, WT; Gold, JM; Lahti, AC; Queern, CA; Conley, RR; Bartko, JJ; Kovnick, J; Appelbaum, PS
      Decisional capacity for informed consent in schizophrenia research

      ARCHIVES OF GENERAL PSYCHIATRY
    12. Carpenter, WT; Conley, RR
      Sense and nonsense: an essay on schizophrenia research ethics

      SCHIZOPHRENIA RESEARCH
    13. Arango, C; Carpenter, WT; Queern, CA
      Research ethics: A psychological approach.

      CLINICAL PSYCHOLOGY REVIEW
    14. Carpenter, WT; Kirkpatrick, B; Buchanan, RW
      Schizophrenia: syndromes and diseases

      JOURNAL OF PSYCHIATRIC RESEARCH
    15. Carpenter, WT
      The schizophrenia ketamine challenge study debate

      BIOLOGICAL PSYCHIATRY
    16. Carpenter, WT; Arango, C; Buchanan, RW; Kirkpatrick, B
      Deficit psychopathology and a paradigm shift in schizophrenia research

      BIOLOGICAL PSYCHIATRY
    17. Carpenter, WT; Zito, JM; Volavka, J
      Dopamine, receptor occupancy and the action of clozapine: Does it make a difference to add a neuroleptic? Reply

      BIOLOGICAL PSYCHIATRY
    18. Carpenter, WT
      The challenge to psychiatry as society's agent for mental illness treatment and research

      AMERICAN JOURNAL OF PSYCHIATRY
    19. Rafal, S; Tsuang, MT; Carpenter, WT
      A dilemma born of progress: Switching from clozapine to a newer antipsychotic

      AMERICAN JOURNAL OF PSYCHIATRY
    20. Arango, C; Adami, H; Sherr, JD; Thaker, GK; Carpenter, WT
      Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness

      AMERICAN JOURNAL OF PSYCHIATRY
    21. Amador, XF; Kirkpatrick, B; Buchanan, RW; Carpenter, WT; Marcinko, L; Yale, SA
      Stability of the diagnosis of deficit syndrome in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    22. Carpenter, WT; Buchanan, RW; Kirkpatrick, B; Lann, HD; Breier, AF; Summerfelt, AT
      Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks

      AMERICAN JOURNAL OF PSYCHIATRY
    23. Carpenter, WT; Buchanan, RW; Kirkpatrick, B; Breier, AF
      Diazepam treatment of early signs of exacerbation in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    24. CARPENTER WT
      ETHICAL PROBLEMS IN PSYCHIATRIC RESEARCH

      JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH
    25. HONG WW; RAK IW; CIURYLA VT; WILSON AM; KYLSTRA JW; MELTZER HY; CARPENTER WT; LEHMAN A; ARVANITIS LA
      MEDICAL-CLAIMS DATABASES IN THE DESIGN OF A HEALTH-OUTCOMES COMPARISON OF QUETIAPINE (SEROQUEL) AND USUAL-CARE ANTIPSYCHOTIC MEDICATION

      Schizophrenia research
    26. CARPENTER WT
      MEDICATION-FREE RESEARCH AND PATIENT SAFETY

      Schizophrenia bulletin
    27. CARPENTER WT
      NEW VIEWS ON THE COURSE AND TREATMENT OF SCHIZOPHRENIA

      Journal of Psychiatric Research
    28. CARPENTER WT; ZITO JM; VITRAI J; VOLAVKA J
      HYPOTHESIS-TESTING - IS CLOZAPINES SUPERIOR EFFICACY DEPENDENT ON MODERATE D-2 RECEPTOR OCCUPANCY

      Biological psychiatry
    29. CARPENTER WT; SCHOOLER NR; KANE JM
      MEDICATION REMOVAL AND RESEARCH IN PSYCHOTIC DISORDERS - IN REPLY

      Archives of general psychiatry
    30. BUCHANAN RW; BREIER A; KIRKPATRICK B; BALL P; CARPENTER WT
      POSITIVE AND NEGATIVE SYMPTOM RESPONSE TO CLOZAPINE IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT THE DEFICIT SYNDROME

      The American journal of psychiatry
    31. Carpenter, WT; Conley, RR; Buchanan, RW
      Schizophrenia

      PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
    32. CARPENTER WT
      ARE PSYCHOPATHOLOGICAL DOMAINS INDEPENDENT DISEASES

      Schizophrenia research
    33. VLADAR K; BUCHANAN RW; CARPENTER WT; BARTA PE; PEARLSON GD
      PREFRONTAL CORTEX IN SCHIZOPHRENIA - A MAGNETIC-RESONANCE-IMAGING STUDY USING ANATOMICALLY RELEVANT LANDMARKS

      Schizophrenia research
    34. LAHTI AC; HOLCOMB HH; CARPENTER WT; ZHAO M; BUCHANAN RW; TAMMINGA CA
      BLOOD-FLOW ACTIVATION DIFFERENCES DURING AN AUDITORY TASK IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT PRIMARY NEGATIVE SYMPTOMS

      Schizophrenia research
    35. BUCHANAN RW; STEVENS JR; CARPENTER WT
      THE NEUROANATOMY OF SCHIZOPHRENIA - INTRODUCTION

      Schizophrenia bulletin
    36. BUCHANAN RW; CARPENTER WT
      THE NEUROANATOMIES OF SCHIZOPHRENIA

      Schizophrenia bulletin
    37. CARPENTER WT
      THE RISK OF MEDICATION-FREE RESEARCH

      Schizophrenia bulletin
    38. LAHTI AC; HOLCOMB HH; CARPENTER WT; ZHAO M; WEILER MA; COREY PK; MEDOFF D; BUCHANAN RW; TAMMINGA CA
      RCBF PATTERN DIFFERENCES BETWEEN DEFICIT AND NONDEFICIT SCHIZOPHRENIC-PATIENTS

      Biological psychiatry
    39. CARPENTER WT; SCHOOLER NR; KANE JM
      THE RATIONALE AND ETHICS OF MEDICATION-FREE RESEARCH IN SCHIZOPHRENIA

      Archives of general psychiatry
    40. CONLEY RR; CARPENTER WT; TAMMINGA CA
      TIME TO CLOZAPINE RESPONSE IN A STANDARDIZED TRIAL

      The American journal of psychiatry
    41. BUSTILLO JR; THAKER G; BUCHANAN RW; MORAN M; KIRKPATRICK B; CARPENTER WT
      VISUAL INFORMATION-PROCESSING IMPAIRMENTS IN DEFICIT AND NONDEFICIT SCHIZOPHRENIA

      The American journal of psychiatry
    42. BUCHANAN RW; STRAUSS ME; BREIER A; KIRKPATRICK B; CARPENTER WT
      ATTENTIONAL IMPAIRMENTS IN DEFICIT AND NONDEFICIT FORMS OF SCHIZOPHRENIA

      The American journal of psychiatry
    43. BUCHANAN RW; CARPENTER WT
      TARGETED MAINTENANCE TREATMENT IN SCHIZOPHRENIA - ISSUES AND RECOMMENDATIONS

      CNS DRUGS
    44. KIRKPATRICK B; AMADOR XF; FLAUM M; YALE SA; GORMAN JM; CARPENTER WT; TOHEN M; MCGLASHAN T
      THE DEFICIT SYNDROME IN THE DSM-IV FIELD TRIAL .1. ALCOHOL AND OTHER DRUG-ABUSE

      Schizophrenia research
    45. LAHTI AC; HOLCOMB HH; CARPENTER WT; CAUDILL PJ; ZHAO M; ALBERT PK; MEDOFF DR; TAMMINGA CA
      RCBF PATTERN DIFFERENCES BETWEEN MEDICATION-FREE SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT DEFICIT SYMPTOMS

      Schizophrenia research
    46. HOLCOMB HH; LAHTI AC; CAUDILL PJ; ZHAO Z; MEDOFF DR; CARPENTER WT; ALBERT PK; TAMMINGA CA
      RCBF PATTERN CONTRASTS BETWEEN NORMAL VOLUNTEERS AND MEDICATION-FREE SCHIZOPHRENICS DERIVED FROM A DIFFICULT TONE RECOGNITION TASK

      Schizophrenia research
    47. AMADOR XF; KIRKPATRICK B; CARPENTER WT; YALE SA; MARCINKO L
      THE LONG-TERM STABILITY OF THE DEFICIT SYNDROME

      Schizophrenia research
    48. CARPENTER WT
      MAINTENANCE THERAPY OF PERSONS WITH SCHIZOPHRENIA

      The Journal of clinical psychiatry
    49. CARPENTER WT; MCGUFFIN P; MELLOR CS; TORREY EF; OGRADY J; GEDDES JR; CHRISTOFI G; SACKETT DL; WING J; HAFNER H; CROW TJ
      FIRST-RANK SYMPTOMS OR RANK-AND-FILE SYMPTOMS - COMMENTARY

      British Journal of Psychiatry
    50. CARPENTER WT
      TREATMENT OF NEGATIVE SYMPTOMS - PHARMACOLOGICAL AND METHODOLOGICAL ISSUES

      British Journal of Psychiatry
    51. CARPENTER WT; CONLEY RR; BUCHANAN RW; BREIER A; TAMMINGA CA
      CLOZAPINE CONFLICT

      The American journal of psychiatry
    52. CARPENTER WT; BUCHANAN RW; KIRKPATRICK B
      NEW DIAGNOSTIC ISSUES IN SCHIZOPHRENIC DISORDERS

      Clinical neuroscience
    53. KIRKPATRICK B; AMADOR X; YALE S; GORMAN JM; CARPENTER WT
      DRUG-ABUSE AMONG DEFICIT AND NONDEFICIT SCHIZOPHRENIC-PATIENTS IN THEDSM-IV FIELD TRIALS

      Schizophrenia research
    54. WALTRIP RW; BUCHANAN RW; SUMMERFELT A; BREIER A; CARPENTER WT; BRYANT NL; KIRKPATRICK B; RUBIN SA; CARBONE KM
      BORNA-DISEASE VIRUS-ANTIBODIES AND SCHIZOPHRENIA

      Schizophrenia research
    55. LAHTI AC; TAMMINGA CA; HOLCOMB HH; CAUDILL PJ; ZHAO M; MEDOFF DR; CARPENTER WT
      RCBF PATTERN DIFFERENCES BETWEEN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT ENDURING NEGATIVE SYMPTOMS (DEFICIT SYMPTOMS)

      Schizophrenia research
    56. BUCHANAN RW; CARPENTER WT; KIRKPATRICK B; BRYANT N; BUSTILLO J
      DOPAMINE AGENTS FOR THE TREATMENT OF THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

      Schizophrenia research
    57. BUSTILLO J; BUCHANAN RW; CARPENTER WT
      PRODROMAL SYMPTOMS VS EARLY WARNING SIGNS AND CLINICAL ACTION IN SCHIZOPHRENIA

      Schizophrenia bulletin
    58. LEHMAN AF; CARPENTER WT; GOLDMAN HH; STEINWACHS DM
      TREATMENT OUTCOMES IN SCHIZOPHRENIA - IMPLICATIONS FOR PRACTICE, POLICY, AND RESEARCH

      Schizophrenia bulletin
    59. CARPENTER WT
      SEROTONIN-DOPAMINE ANTAGONISTS AND TREATMENT OF NEGATIVE SYMPTOMS

      Journal of clinical psychopharmacology
    60. WALTRIP RW; BUCHANAN RW; SUMMERFELT A; BREIER A; CARPENTER WT; BRYANT NL; RUBIN SA; CARBONE KM
      BORNA-DISEASE VIRUS AND SCHIZOPHRENIA

      Psychiatry research
    61. KIRKPATRICK B; CARPENTER WT
      DRUG DEVELOPMENT AND THE DEFICIT SYNDROME OF SCHIZOPHRENIA

      Biological psychiatry
    62. CARPENTER WT; TAMMINGA CA
      WHY NEUROLEPTIC WITHDRAWAL IN SCHIZOPHRENIA

      Archives of general psychiatry
    63. CARPENTER WT; CONLEY RR; BUCHANAN RW; BREIER A; TAMMINGA CA
      PATIENT RESPONSE AND RESOURCE-MANAGEMENT - ANOTHER VIEW OF CLOZAPINE TREATMENT OF SCHIZOPHRENIA

      The American journal of psychiatry
    64. PULVER AE; KARAYIORGOU M; WOLYNIEC PS; LASSETER VK; KASCH L; NESTADT G; ANTONARAKIS S; HOUSMAN D; KAZAZIAN HH; MEYERS D; OTT J; LAMACZ M; LIANG KY; HANFELT J; ULLRICH G; DEMARCHI N; RAMU E; MCHUGH PR; ADLER L; THOMAS M; CARPENTER WT; MANSCHRECK T; GORDON CT; KIMBERLAND M; BABB R; PUCK J; CHILDS B
      SEQUENTIAL STRATEGY TO IDENTIFY A SUSCEPTIBILITY GENE FOR SCHIZOPHRENIA - REPORT OF POTENTIAL LINKAGE ON CHROMOSOME 22Q12-Q13.1 .1.

      American journal of medical genetics
    65. CARPENTER WT; BUCHANAN RW
      SCHIZOPHRENIA - REPLY

      The New England journal of medicine
    66. CARPENTER WT; BUCHANAN RW
      SCHIZOPHRENIA

      The New England journal of medicine
    67. KIRKPATRICK B; BUCHANAN RW; BREIER A; CARPENTER WT
      DEPRESSIVE SYMPTOMS AND THE DEFICIT SYNDROME OF SCHIZOPHRENIA

      The Journal of nervous and mental disease
    68. BUCHANAN RW; CARPENTER WT
      DOMAINS OF PSYCHOPATHOLOGY - AN APPROACH TO THE REDUCTION OF HETEROGENEITY IN SCHIZOPHRENIA

      The Journal of nervous and mental disease
    69. LIDDLE P; CARPENTER WT; CROW T
      SYNDROMES OF SCHIZOPHRENIA CLASSIC LITERATURE

      British Journal of Psychiatry
    70. CARPENTER WT; BUCHANAN RW; KIRKPATRICK B; TAMMINGA C; WOOD F
      NEURAL CIRCUITS IN SCHIZOPHRENIA

      Archives of general psychiatry
    71. BUCHANAN RW; STRAUSS ME; KIRKPATRICK B; HOLSTEIN C; BREIER A; CARPENTER WT
      NEUROPSYCHOLOGICAL IMPAIRMENTS IN DEFICIT VS NONDEFICIT FORMS OF SCHIZOPHRENIA

      Archives of general psychiatry
    72. CARPENTER WT
      THE DEFICIT SYNDROME

      The American journal of psychiatry
    73. BREIER A; BUCHANAN RW; KIRKPATRICK B; DAVIS OR; IRISH D; SUMMERFELT A; CARPENTER WT
      EFFECTS OF CLOZAPINE ON POSITIVE AND NEGATIVE SYMPTOMS IN OUTPATIENTSWITH SCHIZOPHRENIA

      The American journal of psychiatry
    74. CARPENTER WT; BENES F; CARLSSON A; TAMMINGA C; WEINBERGER DR; GRACE AA
      INTERACTIVE DISCUSSION OF SCHIZOPHRENIA

      Neuropsychopharmacology
    75. ANDREASEN NC; CARPENTER WT
      DIAGNOSIS AND CLASSIFICATION OF SCHIZOPHRENIA

      Schizophrenia bulletin
    76. KIRKPATRICK B; BUCHANAN RW; BREIER A; CARPENTER WT
      CASE IDENTIFICATION AND STABILITY OF THE DEFICIT SYNDROME OF SCHIZOPHRENIA

      Psychiatry research
    77. CARPENTER WT
      PSYCHOSOCIAL TREATMENT OF SCHIZOPHRENIA - COMMENTARY

      Psychiatry
    78. BREIER A; BUCHANAN RW; IRISH D; CARPENTER WT
      CLOZAPINE TREATMENT OF OUTPATIENTS WITH SCHIZOPHRENIA - OUTCOME AND LONG-TERM RESPONSE PATTERNS

      Hospital & community psychiatry
    79. CARPENTER WT; BUCHANAN RW; KIRKPATRICK B; TAMMINGA C; WOOD F
      STRONG INFERENCE, THEORY TESTING, AND THE NEUROANATOMY OF SCHIZOPHRENIA

      Archives of general psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 00:36:34